Abstract
Ephedrine is an alpha-beta agonist widely used for nasal decongestion, nervous system stimulation, and spinal anesthesia during cesarean section. Ephedra was used more than 5000 years ago in China and India for treating fever, flu, cold, chills, nasal congestion, coughing, and wheezing. Pseudoephedrine is an isomer of ephedrine. Ephedrine is a sympathomimetic drug that acts both on α- and β -adrenergic receptors. It directly stimulates α1, β 1, and β 2 adrenergic receptors. Furthermore, it indirectly stimulates the release of noradrenaline from the storage sites. The most important effects are the increase in the heart rate, increase in systolic and diastolic blood pressure, peripheral vasoconstriction, and relaxation of smooth muscle cells of bronchi. By adrenergic stimulation, ephedrine shortens atrial and ventricular refractory periods, permitting the development of both automatic and reentrant arrhythmias.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Henry B. Pseudoephedrine dilemma. W V Med J. 2014;110:6.
Rodos C. Ephedra ban: no shortage of reasons. FDA Consum. 2004;38:6–7.
Maughan RJ. Contamination of dietary supplements and positive drug tests in sport. J Sports Sci. 2005;23:883–9.
Furlanello F, Bentivegna S, Cappato R, De Ambroggi L. Arrhythmogenic effects of illicit drugs in athletes. Ital Heart J. 2003;4:829–37.
Gajraj NM, Wallace DH, Pace NA. Supraventricular tachycardia in a parturient under spinal anesthesia. Reg Anesth. 1993;18:261–3.
Thurn AL, Betz JM. Ephedra. In: Coates PM, Betz JM, Blackman MR, et al., editors. Encyclopedia of dietary supplements. 2nd ed. London, UK: Informa Healthcare; 2010. p. 250–6.
Gosselin RE, Smith RP, Hodge HC. Clinical toxicology of commercial products. 5th ed. Baltimore: Williams and Wilkins; 1984. p. II–370.
Stoelting RK. Sympathomimetics. In: Stoelting RK, editor. Pharmacology and physiology in anesthetic practice. 3rd ed. Philadelphia: Lippincot-Raven; 1999. p. 259–77.
Schier JG, Traub SJ, Hoffman RS, Nelson LS. Ephedrine-induced cardiac ischemia: exposure confirmed with a serum level. J Toxicol Clin Toxicol. 2003;41:849–53.
Cooper DW, Carpenter M, Mowbray P, Desira WR, Ryall DM, Kokri MS. Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology. 2002;97:1582–90.
Natarajan AK, Singh NR, Singh LP, Devi RS, Devi NA, Jack A. Comparison of intravenous bolus phenylephrine and intravenous ephedrine during crystalloid in ameliorating hypotension under spinal anesthesia for cesarean section. J Med Soc. 2015;29:155–9.
Adamson PB, Suarez J, Ellis E, Kanaly T, Vanoli E. Ephedrine increases ventricular arrhythmias in conscious dogs after myocardial infarction. J Am Coll Cardiol. 2004;44:1675–8.
Loughrey JP, Yao N, Datta S, Segal S, Pian-Smith M, Tsen LC. Hemodynamic effects of spinal anesthesia and simultaneous intravenous bolus of combined phenylephrine and ephedrine versus ephedrine for cesarean delivery. Int J Obstet Anesth. 2005;14:43–7.
Chan WS, Irwin MG, Tong WN, Lam YH. Prevention of hypotension during spinal anaesthesia for cesarean section: ephedrine infusion versus fluid preload. Anaesthesia. 1997;52:908–13.
King SW, Rosen MA. Prophylactic ephedrine and hypotension associated with spinal anesthesia for cesarean delivery. Int J Obstet Anesth. 1998;7:18–22.
Lee A, Ngan Kee WD, Gin T. A dose-response meta- analysis of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for elective cesarean delivery. Anesth Analg. 2004;98:483–90.
Ngan Kee WD, Khaw KS, Lee BB, Lau TK, Gin T. A dose-response study of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg. 2000;90:1390–5.
Datta S, Alper MH, Osthemer GW, Weiss JB. Method of ephedrine administration and nausea and hypotension during spinal anesthesia for cesarean section. Anesthesiology. 1982;56:68–70.
Kol IO, Kaygusuz K, Gursoy S, Cetin A, Kahramanoglu Z, Ozkan F, et al. The effects of intravenous ephedrine during spinal anesthesia for cesarean delivery: a randomized controlled trial. J Korean Med Sci. 2009;24:883–8.
Cassela M, Dello Russo A, Izzo G, Pieroni M, Andreini D, Russo E, et al. Ventricular arrhythmias induced by long-term use of ephedrine in two competitive athletes. Heart Vessels. 2015;30:280–3.
Abraham J, Mudd JO, Kapur NK, Champion HC, Klein K, Wittstein IS. Stress cardiomyopathy after intravenous administration of cathecolamines and beta-receptor agonists. J Am Coll Cardiol. 2009;53:1320–5.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Moosavi-Shalheh, A. (2019). How to Induce Arrhythmias with Ephedrine?. In: Cismaru, G. (eds) Arrhythmia Induction in the EP Lab. Springer, Cham. https://doi.org/10.1007/978-3-319-92729-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-92729-9_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92728-2
Online ISBN: 978-3-319-92729-9
eBook Packages: MedicineMedicine (R0)